[
  {
    "criterion": "Provides accurate information about the types of hydatidiform moles and their characteristics.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Fails to mention the importance of Î²-hCG levels in diagnosing and monitoring molar pregnancies.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Does not clarify the differences between complete and partial hydatidiform moles.",
    "axis": "context_awareness",
    "point": -3
  },
  {
    "criterion": "Uses natural language and correct interpretation in its responses.",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Does not provide guidance on the recommended first-line chemotherapy regimen for persistent GTN.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Provides accurate information about the characteristics of persistent GTN and its management.",
    "axis": "accuracy",
    "point": 9
  },
  {
    "criterion": "Does not consider alternative treatments or management options for persistent GTN.",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Correctly recommends further workup (imaging, additional labs) to confirm persistent GTN.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Fails to provide information about the importance of follow-up care after molar pregnancy treatment.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Provides accurate information about the risk scoring for persistent GTN.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Does not clarify the role of methotrexate and actinomycin-D in the management of persistent GTN.",
    "axis": "context_awareness",
    "point": -4
  }
]